67 Publications (Page 2 of 3)
2020
Phase II trial of atezolizumab plus chemotherapy after progression on single-agent PD-1 or PD-L1 inhibitor in cisplatin ineligible patients with advanced urothelial carcinoma HCRN GU17-295Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Hauke, Ralph J⋅Hauke, Ralph J⋅Hauke, Ralph J⋅Kaimakliotis, Hristos Z⋅Kaimakliotis, Hristos Z⋅Kaimakliotis, Hristos Z⋅Gulati, Shuchi⋅Gulati, Shuchi⋅Gulati, Shuchi⋅Hashemi, Neda⋅Hashemi, Neda⋅Hashemi, Neda⋅Pili, Roberto⋅Pili, Roberto and Pili, RobertoJournal of Clinical Oncology, vol. 38, (no. 6_suppl), pp. TPS587, 2020-02-20.
| Journal Article
Prognostic significance of rate of tumor marker (TM) decline during high-dose chemotherapy (HDCT) for relapsed germ cell tumors (rGCT)Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Liu, Hao⋅Liu, Hao⋅Liu, Hao⋅Liu, Hao⋅Liu, Hao⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Einhorn, Lawrence⋅Einhorn, Lawrence⋅Einhorn, Lawrence⋅Einhorn, Lawrence and Einhorn, LawrenceJournal of Clinical Oncology, vol. 38, (no. 6_suppl), pp. 403, 2020-02-20.
| Journal Article
Prognostic Value of Teratoma in Primary Tumor and Postchemotherapy Retroperitoneal Lymph Node Dissection Specimens in Patients With Metastatic Germ Cell TumorTaza, Fadi⋅Taza, Fadi⋅Taza, Fadi⋅Taza, Fadi⋅Taza, Fadi⋅Taza, Fadi⋅Chovanec, Michal⋅Chovanec, Michal⋅Chovanec, Michal⋅Chovanec, Michal⋅Chovanec, Michal⋅Chovanec, Michal⋅Snavely, Anna⋅Snavely, Anna⋅Snavely, Anna⋅Snavely, Anna⋅Snavely, Anna⋅Snavely, Anna⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Cary, Clint⋅Cary, Clint⋅Cary, Clint⋅Cary, Clint⋅Cary, Clint⋅Cary, Clint⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Foster, Richard S⋅Foster, Richard S⋅Foster, Richard S⋅Foster, Richard S⋅Foster, Richard S⋅Foster, Richard S⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil and Adra, NabilJournal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 38, (no. 12), pp. 1345, 2020-Apr-20.
| Journal Article
Prolonged Survival With Reinstitution of High-Dose Chemotherapy With Peripheral Blood Stem-Cell Transplantation in a Patient With Refractory Testis CancerYan, Melissa N⋅Yan, Melissa N⋅Adra, Nabil⋅Adra, Nabil⋅Einhorn, Lawrence H and Einhorn, Lawrence HJCO oncology practice, vol. 16, (no. 2), pp. 92, 2020-Feb.
| Journal Article
Prolonged Survival With Reinstitution of High-Dose Chemotherapy With Peripheral Blood Stem-Cell Transplantation in a Patient With Refractory Testis Cancer.Yan, Melissa N⋅Adra, Nabil and Einhorn, Lawrence HJCO oncology practice, vol. 16, (no. 2), pp. 91-92, February 2020.
| Journal Article
Risk Factors for Acute Kidney Injury During High-dose Chemotherapy and Outcomes for Patients With Relapsed Germ Cell TumorsZhang, Kevin Juan⋅Zhang, Kevin Juan⋅Zhang, Kevin Juan⋅Zhang, Kevin Juan⋅Zhang, Kevin Juan⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Zaid, Mohammad Abu⋅Zaid, Mohammad Abu⋅Zaid, Mohammad Abu⋅Zaid, Mohammad Abu⋅Zaid, Mohammad Abu⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil and Adra, NabilClinical Genitourinary Cancer, 2020-Feb-08.
| Journal Article
Rucaparib for recurrent, locally advanced, or metastatic urothelial carcinoma (mUC): Results from ATLAS, a phase II open-label trialGrivas, Petros⋅Loriot, Yohann⋅Feyerabend, Susan⋅Morales-Barrera, Rafael⋅Teo, Min Yuen⋅Vogelzang, Nicholas J⋅Grande, Enrique⋅Zakharia, Yousef⋅Adra, Nabil⋅Alva, Ajjai Shivaram⋅Necchi, Andrea⋅Gupta, Sumati⋅Josephs, Debra Hannah⋅Rodriguez-Vida, Alejo⋅Srinivas, Sandy⋅Wride, Kenton⋅Thomas, Daleen⋅Dusek, Rachel⋅Nepert, Dale L and Chowdhury, SimonJournal of Clinical Oncology, vol. 38, (no. 6_suppl), pp. 440, 2020-02-20.
| Journal Article
Tumor frameshift mutation proportion predicts response to immunotherapy in mismatch repair-deficient prostate cancer.Sena, Laura A⋅Sena, Laura A⋅Sena, Laura A⋅Fountain, Julia⋅Fountain, Julia⋅Fountain, Julia⋅Isaacsson Velho, Pedro⋅Isaacsson Velho, Pedro⋅Isaacsson Velho, Pedro⋅Lim, Su Jin⋅Lim, Su Jin⋅Lim, Su Jin⋅Wang, Hao⋅Wang, Hao⋅Wang, Hao⋅Nizialek, Emily⋅Nizialek, Emily⋅Nizialek, Emily⋅Rathi, Nityam⋅Rathi, Nityam⋅Rathi, Nityam⋅Nussenzveig, Roberto⋅Nussenzveig, Roberto⋅Nussenzveig, Roberto⋅Maughan, Benjamin L⋅Maughan, Benjamin L⋅Maughan, Benjamin L⋅Velez, Miguel Gonzalez⋅Velez, Miguel Gonzalez⋅Velez, Miguel Gonzalez⋅Ashkar, Ryan⋅Ashkar, Ryan⋅Ashkar, Ryan⋅Larson, Amanda C⋅Larson, Amanda C⋅Larson, Amanda C⋅Pritchard, Colin C⋅Pritchard, Colin C⋅Pritchard, Colin C⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Bryce, Alan H⋅Bryce, Alan H⋅Bryce, Alan H⋅Agarwal, Neeraj⋅Agarwal, Neeraj⋅Agarwal, Neeraj⋅Pardoll, Drew M⋅Pardoll, Drew M⋅Pardoll, Drew M⋅Eshleman, James R⋅Eshleman, James R⋅Eshleman, James R⋅Lotan, Tamara L⋅Lotan, Tamara L⋅Lotan, Tamara L⋅Antonarakis, Emmanuel S⋅Antonarakis, Emmanuel S and Antonarakis, Emmanuel SThe oncologist, November 20, 2020.
| Journal Article
Urothelial carcinoma in situ response to cisplatin-based neoadjuvant chemotherapy, or lack thereof: Impact on patient selection for organ preservation in muscle-invasive disease?Tachibana, Isamu⋅Bandali, Elhaam⋅Calaway, Adam C⋅Krishnan, Naveen⋅Cheng, Liang⋅Adra, Nabil and Kaimakliotis, Hristos ZUrologic oncology, vol. 38, (no. 11), pp. 850.e1-850.e7, November 2020.
| Journal Article
2019
High-Dose Chemotherapy and Autologous Stem Cell TransplantAdra, Nabil⋅Adra, Nabil⋅Abonour, Rafat, MD and Abonour, RafatUrologic Clinics of North America, vol. 46, (no. 3), pp. 448, 2019.
| Journal Article
Immunomodulation by HDAC inhibition: Results from a phase Ib study with vorinostat and pembrolizumab in metastatic urothelial, renal, and prostate carcinoma patientsPili, Roberto⋅Pili, Roberto⋅Pili, Roberto⋅Pili, Roberto⋅Pili, Roberto⋅Pili, Roberto⋅Quinn, David I⋅Quinn, David I⋅Quinn, David I⋅Quinn, David I⋅Quinn, David I⋅Quinn, David I⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Logan, Theodore F⋅Logan, Theodore F⋅Logan, Theodore F⋅Logan, Theodore F⋅Logan, Theodore F⋅Logan, Theodore F⋅Greenspan, Andrew⋅Greenspan, Andrew⋅Greenspan, Andrew⋅Greenspan, Andrew⋅Greenspan, Andrew⋅Greenspan, Andrew⋅Budka, Justin⋅Budka, Justin⋅Budka, Justin⋅Budka, Justin⋅Budka, Justin⋅Budka, Justin⋅Damayanti, Nur⋅Damayanti, Nur⋅Damayanti, Nur⋅Damayanti, Nur⋅Damayanti, Nur⋅Green, Mark A⋅Green, Mark A⋅Green, Mark A⋅Green, Mark A⋅Green, Mark A⋅Green, Mark A⋅Fletcher, James W⋅Fletcher, James W⋅Fletcher, James W⋅Fletcher, James W⋅Fletcher, James W⋅Fletcher, James W⋅Tann, Mark⋅Tann, Mark⋅Tann, Mark⋅Tann, Mark⋅Tann, Mark⋅Tann, Mark⋅Edwards, Sara I⋅Edwards, Sara I⋅Edwards, Sara I⋅Edwards, Sara I⋅Edwards, Sara I⋅Edwards, Sara I⋅Burney, Heather⋅Burney, Heather⋅Burney, Heather⋅Burney, Heather⋅Burney, Heather⋅Burney, Heather⋅Liu, Hao⋅Liu, Hao⋅Liu, Hao⋅Liu, Hao⋅Liu, Hao⋅Liu, Hao⋅Hahn, Noah M⋅Hahn, Noah M⋅Hahn, Noah M⋅Hahn, Noah M⋅Hahn, Noah M and Hahn, Noah MJournal of Clinical Oncology, vol. 37, (no. 15_suppl), pp. 2572, 2019-05-20.
| Journal Article
PD52-03 A MULTICENTER PHASE 1B/2 STUDY OF NEOADJUVANT PEMBROLIZUMAB AND CISPLATIN CHEMOTHERAPY FOR MUSCLE INVASIVE UROTHELIAL CANCERKaimakliotis, Hristos⋅Kaimakliotis, Hristos⋅Albany, Costantine⋅Albany, Costantine⋅Hoffman-Censits, Jean⋅Hoffman-Censits, Jean⋅Trabulsi, Edouard⋅Trabulsi, Edouard⋅Kelly, W. Kevin⋅Kelly, W. Kevin⋅Picus, Joel⋅Picus, Joel⋅Adra, Nabil⋅Adra, Nabil⋅Cary, Clint⋅Cary, Clint⋅Koch, Michael⋅Koch, Michael⋅Fleming, Mark⋅Fleming, Mark⋅Walling, Radhika⋅Walling, Radhika⋅Godwin, J. Luke⋅Godwin, J. Luke⋅Abouassaly, Robert⋅Abouassaly, Robert⋅Cooney, Matthew⋅Cooney, Matthew⋅Fu, Pingfu⋅Fu, Pingfu⋅Nelson, Ariel⋅Nelson, Ariel⋅Xavier, Ginu⋅Xavier, Ginu⋅Ponsky, Lee⋅Ponsky, Lee⋅Hoimes, Christopher and Hoimes, ChristopherJournal of Urology, vol. 201, (no. Supplement 4), 2019-04-00.
| Journal Article
Phase I study of the mTOR inhibitor everolimus in combination with the histone deacetylase inhibitor panobinostat in patients with advanced clear cell renal cell carcinomaWood, Anthony⋅Wood, Anthony⋅Wood, Anthony⋅George, Saby⋅George, Saby⋅George, Saby⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Chintala, Sreenivasulu⋅Chintala, Sreenivasulu⋅Chintala, Sreenivasulu⋅Damayanti, Nur⋅Damayanti, Nur⋅Damayanti, Nur⋅Pili, Roberto⋅Pili, Roberto and Pili, RobertoInvestigational new drugs, 2019-Oct-25.
| Journal Article
Prognostic value of serum tumor marker (STM) rate of decline during high-dose chemotherapy (HDCT) and peripheral-blood stem-cell transplant (PBSCT) for relapsed germ-cell tumors (rGCT)Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Liu, Hao⋅Liu, Hao⋅Liu, Hao⋅Liu, Hao⋅Liu, Hao⋅Liu, Hao⋅Liu, Hao⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Cary, Clint⋅Cary, Clint⋅Cary, Clint⋅Cary, Clint⋅Cary, Clint⋅Cary, Clint⋅Cary, Clint⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Foster, Richard⋅Foster, Richard⋅Foster, Richard⋅Foster, Richard⋅Foster, Richard⋅Foster, Richard⋅Foster, Richard⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H and Einhorn, Lawrence HJournal of Clinical Oncology, vol. 37, (no. 15_suppl), pp. e16044, 2019-05-20.
| Journal Article
Prolonged Survival With Reinstitution of High-Dose Chemotherapy With Peripheral Blood Stem-Cell Transplantation in a Patient With Refractory Testis CancerYan, Melissa N⋅Yan, Melissa N⋅Adra, Nabil⋅Adra, Nabil⋅Einhorn, Lawrence H and Einhorn, Lawrence HJournal of Oncology Practice, pp. JOP1900361, 2019-11-13.
| Journal Article
Risk factors for renal failure (RF) during high-dose chemotherapy (HDCT) and outcomes for patients (pts) with relapsed germ-cell tumors (rGCT)Zhang, Kevin Juan⋅Zhang, Kevin Juan⋅Zhang, Kevin Juan⋅Zhang, Kevin Juan⋅Zhang, Kevin Juan⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil and Adra, NabilJournal of Clinical Oncology, vol. 37, (no. 15_suppl), pp. e16042, 2019-05-20.
| Journal Article
Salvage therapy for relapsed testicular cancer: a need for consensusAgrawal, Vaibhav and Adra, NabilFuture oncology (London, England), vol. 15, (no. 34), pp. 3881, 2019-Dec.
| Journal Article
Structural variation and fusion detection using targeted sequencing data from circulating cell free DNAGawroński, Alexander R⋅Gawroński, Alexander R⋅Lin, Yen-Yi⋅Lin, Yen-Yi⋅McConeghy, Brian⋅McConeghy, Brian⋅LeBihan, Stephane⋅LeBihan, Stephane⋅Asghari, Hossein⋅Asghari, Hossein⋅Koçkan, Can⋅Koçkan, Can⋅Orabi, Baraa⋅Orabi, Baraa⋅Adra, Nabil⋅Adra, Nabil⋅Pili, Roberto⋅Pili, Roberto⋅Collins, Colin C⋅Collins, Colin C⋅Sahinalp, S Cenk⋅Sahinalp, S Cenk⋅Hach, Faraz and Hach, FarazNucleic Acids Research, vol. 47, (no. 7), pp. e38, 20190423.
| Journal Article
Survival and toxicity outcomes in patients age 40 or older with relapsed metastatic germ cell tumors (mGCT) treated with high-dose chemotherapy (HDCT) and autologous peripheral-blood stem cell transplant (PBSCT)Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Pereira, Dannillo⋅Pereira, Dannillo⋅Pereira, Dannillo⋅Pereira, Dannillo⋅Pereira, Dannillo⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Sullivan, Cheryl K⋅Sullivan, Cheryl K⋅Sullivan, Cheryl K⋅Sullivan, Cheryl K⋅Sullivan, Cheryl K⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H and Einhorn, Lawrence HJournal of Clinical Oncology, vol. 37, (no. 7_suppl), pp. 522, 2019-03-01.
| Journal Article
2018
Adverse health outcomes (AHO) after modern cisplatin-based chemotherapy (CHEM) compared to surgery-only: A study of 503 testicular cancer survivors (TCS)Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Cary, Clint⋅Cary, Clint⋅Cary, Clint⋅Cary, Clint⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Monahan, Patrick O⋅Monahan, Patrick O⋅Monahan, Patrick O⋅Monahan, Patrick O⋅Norton, Kelli⋅Norton, Kelli⋅Norton, Kelli⋅Norton, Kelli⋅Cook, Ryan⋅Cook, Ryan⋅Cook, Ryan⋅Cook, Ryan⋅Einhorn, Lawrence⋅Einhorn, Lawrence⋅Einhorn, Lawrence⋅Einhorn, Lawrence⋅Travis, Lois B⋅Travis, Lois B⋅Travis, Lois B and Travis, Lois BJournal of Clinical Oncology, vol. 36, (no. 15_suppl), pp. e22068, 2018-05-20.
| Journal Article
Retroperitoneal cancer viability after postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) in good risk germ cell tumors (GCTs)Taza, Fadi⋅Taza, Fadi⋅Taza, Fadi⋅Taza, Fadi⋅Chovanec, Michal⋅Chovanec, Michal⋅Chovanec, Michal⋅Chovanec, Michal⋅Snavely, Anna⋅Snavely, Anna⋅Snavely, Anna⋅Snavely, Anna⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Cary, Clint⋅Cary, Clint⋅Cary, Clint⋅Cary, Clint⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine and Albany, CostantineJournal of Clinical Oncology, vol. 36, (no. 15_suppl), pp. 4551, 2018-05-20.
| Journal Article
Risk of Bleomycin-Related Pulmonary Toxicities and Operative Morbidity After Postchemotherapy Retroperitoneal Lymph Node Dissection in Patients With Good-Risk Germ Cell TumorsCalaway, Adam C⋅Calaway, Adam C⋅Foster, Richard S⋅Foster, Richard S⋅Adra, Nabil⋅Adra, Nabil⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Albany, Costa⋅Albany, Costa⋅Hanna, Nassar H⋅Hanna, Nassar H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Cary, Clint and Cary, ClintJournal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 36, (no. 29), pp. 2954, 2018-10-10.
| Journal Article
Survival outcomes in plasmacytoid urothelial carcinoma: Results with contemporary systemic therapyHashemi-Sadraei, Neda⋅Hashemi-Sadraei, Neda⋅Hashemi-Sadraei, Neda⋅Hashemi-Sadraei, Neda⋅Hashemi-Sadraei, Neda⋅Hashemi-Sadraei, Neda⋅Perrino, Carmen M.⋅Perrino, Carmen M⋅Perrino, Carmen M⋅Perrino, Carmen M⋅Perrino, Carmen M⋅Perrino, Carmen M⋅Monn, M. Francesca⋅Monn, M. Francesca⋅Monn, M. Francesca⋅Monn, M. Francesca⋅Monn, M. Francesca⋅Monn, M. Francesca⋅Bandali, Elhaam⋅Bandali, Elhaam⋅Bandali, Elhaam⋅Bandali, Elhaam⋅Bandali, Elhaam⋅Bandali, Elhaam⋅Cheng, Liang⋅Cheng, Liang⋅Cheng, Liang⋅Cheng, Liang⋅Cheng, Liang⋅Cheng, Liang⋅Idrees, Muhammad⋅Idrees, Muhammad⋅Idrees, Muhammad⋅Idrees, Muhammad⋅Idrees, Muhammad⋅Idrees, Muhammad⋅Bihrle, Richard⋅Bihrle, Richard⋅Bihrle, Richard⋅Bihrle, Richard⋅Bihrle, Richard⋅Bihrle, Richard⋅Koch, Michael O⋅Koch, Michael O.⋅Koch, Michael O⋅Koch, Michael O⋅Koch, Michael O⋅Koch, Michael O⋅Eble, John⋅Eble, John⋅Eble, John⋅Eble, John⋅Eble, John⋅Eble, John⋅Kao, Chia-Sui⋅Kao, Chia-Sui⋅Kao, Chia-Sui⋅Kao, Chia Sui⋅Kao, Chia-Sui⋅Kao, Chia-Sui⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅al.⋅Pili, Roberto⋅Pili, Roberto⋅Pili, Roberto⋅Pili, Roberto⋅Pili, Roberto⋅Grignon, David A⋅Grignon, David A⋅Grignon, David A⋅Grignon, David A⋅Grignon, David A⋅Kaimakliotis, Hristos Z⋅Kaimakliotis, Hristos Z⋅Kaimakliotis, Hristos Z⋅Kaimakliotis, Hristos Z⋅Kaimakliotis, Hristos Z⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine and Albany, CostantineJournal of Clinical Oncology, vol. 36, (no. 15_suppl), pp. e16525, 2018-05-20.
| Journal Article
The prognostic value of teratoma in the primary tumor and postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) specimens in patients with germ cell tumors (GCTs)Taza, Fadi⋅Taza, Fadi⋅Taza, Fadi⋅Taza, Fadi⋅Chovanec, Michal⋅Chovanec, Michal⋅Chovanec, Michal⋅Chovanec, Michal⋅Snavely, Anna⋅Snavely, Anna⋅Snavely, Anna⋅Snavely, Anna⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Cary, Clint⋅Cary, Clint⋅Cary, Clint⋅Cary, Clint⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Masterson, Timothy A⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine and Albany, CostantineJournal of Clinical Oncology, vol. 36, (no. 15_suppl), pp. 4553, 2018-05-20.
| Journal Article
2017
High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University ExperienceAdra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H and Einhorn, Lawrence HJournal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 35, (no. 10), pp. 1102, 2017-Apr-01.
| Journal Article
